In this Issue:
β-blockers in HF + AF
Endostatin for predicting outcomes in chronic HF with poor kidney function
Predictors of BNP nonresponse in acute HF
Sympathetic activation in HF and the obesity paradox
E/A ratio for predicting survival in chronic HF and after acute MI
ARNI vs. enalapril and progression risk in HF survivors
Mechanical dyssynchrony as a therapeutic target in HFPEF
Cognitive status in hospitalised acute decompensated HF
Mortality risk score in noncardiac surgical patients with HF
Chocolate consumption and HF risk
Angina and HFREF outcomes
Please login below to download this issue (PDF)